Multiplex Biomarker Imaging Market: By Product Type (Instrument, Reagents and Kits, Software), By Imaging Technique (Tissue Microarray (TMA), Toponome Imaging System (TIS), Fluorescent In The Situ Hybridization (FISH), Immunofluorescence Assay (IF), Immunohistochemistry Assay (IHC)), By Application (Oncology, Immunology, Drug Safety, Drug Discovery), By End-User (Biotechnology and Pharmaceutical Companies, Academic Research Institutes, Contract Research Organizations), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Multiplex Biomarker Imaging Market size was valued at USD 561.2 million in 2022 and is poised to grow at a CAGR of 12.1% from 2023-2029. An increase in the adoption of the multiplex biomarker in immunology and oncology research, growing R&D investments by pharmaceutical and biotechnology companies, an increase in demand for personalized medicine, and innovation of newer technologies in biomarker imaging are anticipated to fuel the multiplex biomarker imaging market size over the forecast period. Moreover, an increase in preference for companion diagnostics and the advantages of multiplex biomarker imaging over conventional methods are anticipated to boost the multiplex biomarker imaging market report over the forecast years. However, the high cost of the instruments, ethical issues of biomarker imaging techniques, and stringent regulatory policies are anticipated to impede the growth of the market. Multiplex biomarker imaging is a technique carried to characterize and analyze the disease present in the body. Biomarkers are used in clinical studies to determine the disease's progress. Multiplex biomarkers have a major role in the medical industry and these are used in alone or combination to determine the characteristics and evaluate as an indicator of biological process. Multiplex biomarkers also help in the study of biological system by providing analysis to check the expression of various biomarkers. In August 2017, Quanterix launched high-sensitivity instrument Quanterix SR-Plex and assays for multiplex biomarker detection.

Multiplex Biomarker Imaging Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Multiplex Biomarker Imaging Market Dynamics

Multiplex biomarker imaging market expected to exhibit significant growth due to successful determination and validation of clinical data for various diseases related to cancer cells and immune cells. Majority of the market players are actively involved in the development of newer products and techniques to determine the disease progress. For instance, in December 2015, PerkinElmer, Inc. launched Vectra 3 system used to determine the deeper level analysis of disease mechanisms related to newer cancer immunotherapy approaches. Moreover, in September 2017, Aushon BioSystems and ABL, Inc. announced the adoption of Cira platform for ultrasensitive and multiplex biomarker analysis.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Multiplex Biomarker Imaging Market Segmentation

By Product Type
  • Instrument
  • Reagents and Kits
  • Software
By Imaging Technique
  • Tissue Microarray (TMA)
  • Toponome Imaging System (TIS)
  • Fluorescent In The Situ Hybridization (FISH)
  • Immunofluorescence Assay (IF)
  • Immunohistochemistry Assay (IHC)
By Application
  • Oncology
  • Immunology
  • Drug Safety
  • Drug Discovery
By End User
  • Biotechnology and Pharmaceutical Companies
  • Academic Research Institutes
  • Contract Research Organizations

Frequently Asked Questions

The multiplex biomarker imaging market size was valued at USD 561.2 million in 2022

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The multiplex biomarker imaging market key players are Bio-rad Laboratories Inc. (U.S.) Abcam plc. (U.K.) Perkin Elmer, Inc. (U.S.) Thermo Fisher Scientific, Inc. (U.S.) Merck KGaA (Germany) Aushon BioSystems Ltd. (U.S.)

1. Executive Summary
2. Global Multiplex Biomarker Imaging Market Introduction 
2.1.Global Multiplex Biomarker Imaging Market  - Taxonomy
2.2.Global Multiplex Biomarker Imaging Market  - Definitions
2.2.1.Product Type
2.2.2.Imaging Technique
2.2.3.Application
2.2.4.End User
2.2.5.Region
3. Global Multiplex Biomarker Imaging Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Multiplex Biomarker Imaging Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Multiplex Biomarker Imaging Market  By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Instrument
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Reagents and Kits
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Software
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Multiplex Biomarker Imaging Market  By Imaging Technique, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Tissue Microarray (TMA)
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Toponome Imaging System (TIS)
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Fluorescent In The Situ Hybridization (FISH)
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Immunofluorescence Assay (IF)
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Immunohistochemistry Assay (IHC)
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Multiplex Biomarker Imaging Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Oncology
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Immunology
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Drug Safety
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Drug Discovery
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Multiplex Biomarker Imaging Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Biotechnology and Pharmaceutical Companies
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Academic Research Institutes
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Contract Research Organizations
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Global Multiplex Biomarker Imaging Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Multiplex Biomarker Imaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Instrument
10.1.2.Reagents and Kits
10.1.3.Software
10.2.  Imaging Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Tissue Microarray (TMA)
10.2.2.Toponome Imaging System (TIS)
10.2.3.Fluorescent In The Situ Hybridization (FISH)
10.2.4.Immunofluorescence Assay (IF)
10.2.5.Immunohistochemistry Assay (IHC)
10.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Oncology
10.3.2.Immunology
10.3.3.Drug Safety
10.3.4.Drug Discovery
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Biotechnology and Pharmaceutical Companies
10.4.2.Academic Research Institutes
10.4.3.Contract Research Organizations
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Multiplex Biomarker Imaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Instrument
11.1.2.Reagents and Kits
11.1.3.Software
11.2.  Imaging Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Tissue Microarray (TMA)
11.2.2.Toponome Imaging System (TIS)
11.2.3.Fluorescent In The Situ Hybridization (FISH)
11.2.4.Immunofluorescence Assay (IF)
11.2.5.Immunohistochemistry Assay (IHC)
11.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Oncology
11.3.2.Immunology
11.3.3.Drug Safety
11.3.4.Drug Discovery
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Biotechnology and Pharmaceutical Companies
11.4.2.Academic Research Institutes
11.4.3.Contract Research Organizations
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
11.5.7.
12. Asia Pacific (APAC) Multiplex Biomarker Imaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Instrument
12.1.2.Reagents and Kits
12.1.3.Software
12.2.  Imaging Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Tissue Microarray (TMA)
12.2.2.Toponome Imaging System (TIS)
12.2.3.Fluorescent In The Situ Hybridization (FISH)
12.2.4.Immunofluorescence Assay (IF)
12.2.5.Immunohistochemistry Assay (IHC)
12.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Oncology
12.3.2.Immunology
12.3.3.Drug Safety
12.3.4.Drug Discovery
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Biotechnology and Pharmaceutical Companies
12.4.2.Academic Research Institutes
12.4.3.Contract Research Organizations
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Multiplex Biomarker Imaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Instrument
13.1.2.Reagents and Kits
13.1.3.Software
13.2.  Imaging Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Tissue Microarray (TMA)
13.2.2.Toponome Imaging System (TIS)
13.2.3.Fluorescent In The Situ Hybridization (FISH)
13.2.4.Immunofluorescence Assay (IF)
13.2.5.Immunohistochemistry Assay (IHC)
13.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Oncology
13.3.2.Immunology
13.3.3.Drug Safety
13.3.4.Drug Discovery
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Biotechnology and Pharmaceutical Companies
13.4.2.Academic Research Institutes
13.4.3.Contract Research Organizations
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Multiplex Biomarker Imaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Instrument
14.1.2.Reagents and Kits
14.1.3.Software
14.2.  Imaging Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Tissue Microarray (TMA)
14.2.2.Toponome Imaging System (TIS)
14.2.3.Fluorescent In The Situ Hybridization (FISH)
14.2.4.Immunofluorescence Assay (IF)
14.2.5.Immunohistochemistry Assay (IHC)
14.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Oncology
14.3.2.Immunology
14.3.3.Drug Safety
14.3.4.Drug Discovery
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Biotechnology and Pharmaceutical Companies
14.4.2.Academic Research Institutes
14.4.3.Contract Research Organizations
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Bio-rad Laboratories Inc. (U.S.)
15.2.2.Abcam plc. (U.K.)
15.2.3.Perkin Elmer, Inc. (U.S.)
15.2.4.Thermo Fisher Scientific, Inc. (U.S.)
15.2.5.Merck KGaA (Germany)
15.2.6.Aushon BioSystems Ltd. (U.S.)
15.2.7.ToposNomos Ltd (Germany)
15.2.8.Ventana Medical Systems, Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Bio-rad Laboratories Inc. (U.S.)
  • Abcam plc. (U.K.)
  • Perkin Elmer, Inc. (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Merck KGaA (Germany)
  • Aushon BioSystems Ltd. (U.S.)
  • ToposNomos Ltd (Germany)
  • Ventana Medical Systems, Inc. (U.S.)
  • US Biomax Inc. (U.S.)
  • Quanterix (U.S.)

Adjacent Markets